title: Natalizumab throughout pregnancy: Risk of low platelet count in the newborn at delivery.
authors: Department of neurology, CHU de Poitiers, university of Poitiers, 2, rue de la Milétrie, 86021 Poitiers, France. Electronic address: jonathan.ciron@chu-poitiers.fr.
authors: J
authors: J
authors: Ciron
authors: Department of neurology, centre hospitalier Saint-Philibert, groupe hospitalier, institut catholique de Lille, 115, rue du Grand-But, 59462 Lomme, France.
authors: P
authors: P
authors: Hautecoeur
authors: Department of neurology, CHU de Poitiers, university of Poitiers, 2, rue de la Milétrie, 86021 Poitiers, France.
authors: S
authors: S
authors: Mathis
authors: Department of neurology, CHU de Poitiers, university of Poitiers, 2, rue de la Milétrie, 86021 Poitiers, France.
authors: J-P
authors: JP
authors: Neau
mesh_terms: D000328:Adult; D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D007231:Infant, Newborn / Q000097:blood; D007232:Infant, Newborn, Diseases / Q000097:blood / Q000139:chemically induced*; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D000069442:Natalizumab / Q000627:therapeutic use*; D010976:Platelet Count; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011297:Prenatal Exposure Delayed Effects / Q000097:blood* / Q000139:chemically induced; D012307:Risk Factors; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000151:congenital
chemical_list: D000069442:Natalizumab